Natural killer cell as a potential predictive biomarker for early immune checkpoint inhibitor-associated cardiovascular adverse events: a retrospective cohort study
Natural killer cell as a potential predictive biomarker for early immune checkpoint inhibitor-associated cardiovascular adverse events: a retrospective cohort study
Yuxi Zhu, Min Mao, Zhulu Chen, Diansa Gao et al.
Journal
Frontiers in Oncology
Topics
Cancer Immunotherapy and Biomarkers
article
Natural killer cell as a potential predictive biomarker for early immune checkpoint inhibitor-associated cardiovascular adverse events: a retrospective cohort study
Yuxi Zhu, Min Mao, Zhulu Chen, Diansa Gao, Yue Liu, Chuan Zhang, Zhong Zuo, Yujuan Wu, Li Tan
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in OncologyVol. 15
Institutions
The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Chongqing Cancer Hospital (CN), First Hospital of Xi'an (CN), Chongqing Medical University (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Natural killer cell as a potential predictive biomarker for early immune checkpoint inhibitor-associated cardiovascular adverse events: a retrospective cohort study — Yuxi Zhu, Min Mao, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS